Sang‐Goo Shin

1.1k total citations
43 papers, 911 citations indexed

About

Sang‐Goo Shin is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Pharmacology. According to data from OpenAlex, Sang‐Goo Shin has authored 43 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Pharmacology and 11 papers in Pharmacology. Recurrent topics in Sang‐Goo Shin's work include Pharmacogenetics and Drug Metabolism (10 papers), Analytical Methods in Pharmaceuticals (9 papers) and Sexual function and dysfunction studies (6 papers). Sang‐Goo Shin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Analytical Methods in Pharmaceuticals (9 papers) and Sexual function and dysfunction studies (6 papers). Sang‐Goo Shin collaborates with scholars based in South Korea, United States and Ethiopia. Sang‐Goo Shin's co-authors include Kyung‐Sang Yu, Joo‐Youn Cho, In‐Jin Jang, Kyoung Soo Lim, Bo‐Hyung Kim, In‐Jin Jang, Seo Hyun Yoon, SeungHwan Lee, SoJeong Yi and Jae‐Yong Chung and has published in prestigious journals such as CHEST Journal, Clinical Pharmacology & Therapeutics and Vaccine.

In The Last Decade

Sang‐Goo Shin

42 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sang‐Goo Shin South Korea	20	222	200	174	170	137	43	911
Elizabeth Ludwig United States	19	208 0.9×	119 0.6×	156 0.9×	124 0.7×	100 0.7×	59	1.1k
Eric Snoeck Belgium	18	137 0.6×	114 0.6×	100 0.6×	176 1.0×	154 1.1×	44	1.1k
P.A. Soons Netherlands	16	261 1.2×	187 0.9×	164 0.9×	140 0.8×	51 0.4×	27	876
In‐Jin Jang South Korea	14	222 1.0×	153 0.8×	68 0.4×	105 0.6×	91 0.7×	27	660
Adithan Chandrasekaran India	20	383 1.7×	221 1.1×	182 1.0×	216 1.3×	41 0.3×	73	1.2k
Sharon J. Gardiner New Zealand	19	277 1.2×	126 0.6×	64 0.4×	153 0.9×	89 0.6×	41	1.3k
Rasmus S. Pedersen Denmark	19	515 2.3×	317 1.6×	135 0.8×	168 1.0×	53 0.4×	35	1.1k
Atilla Bozkurt Türkiye	21	420 1.9×	239 1.2×	82 0.5×	243 1.4×	114 0.8×	94	1.6k
Bruce K. Birmingham United States	13	189 0.9×	258 1.3×	132 0.8×	66 0.4×	116 0.8×	23	933
Shitalben Patel United States	22	677 3.0×	191 1.0×	266 1.5×	222 1.3×	68 0.5×	66	1.5k

Countries citing papers authored by Sang‐Goo Shin

Since Specialization

Citations

This map shows the geographic impact of Sang‐Goo Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Goo Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Goo Shin more than expected).

Fields of papers citing papers by Sang‐Goo Shin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang‐Goo Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Goo Shin. The network helps show where Sang‐Goo Shin may publish in the future.

Co-authorship network of co-authors of Sang‐Goo Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Sang‐Goo Shin. A scholar is included among the top collaborators of Sang‐Goo Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sang‐Goo Shin. Sang‐Goo Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gu, Namyi, Jae Woo Kim, Kyoung Soo Lim, et al.. (2012). Assessment of the Effect of Mirodenafil on the Hemodynamics of Healthy Male Korean Volunteers Administered Tamsulosin: A Randomized, Double-Blind, Placebo-Controlled, 2-Period Crossover Study. Clinical Therapeutics. 34(9). 1929–1939. 6 indexed citations

Seong, Sook Jin, Mi‐sun Lim, Sung Min Park, et al.. (2012). Results of 2012 KoNECT Certification Program of the Human Resource Project. 20(2). 182–182. 2 indexed citations

Jeon, Hyewon, Kyoung Soo Lim, Kwang‐Hee Shin, et al.. (2011). Assessment of the Drug–Drug Interactions Between Fimasartan and Hydrochlorothiazide in Healthy Volunteers. Journal of Cardiovascular Pharmacology. 59(1). 84–91. 21 indexed citations

Yi, SoJeong, Hyunsuk Shin, Seo Hyun Yoon, et al.. (2011). Pharmacokinetics of Extended-Release Versus Conventional Tramadol/Acetaminophen Fixed-Dose Combination Tablets: An Open-Label, 2-Treatment, Multiple-Dose, Randomized-Sequence Crossover Study in Healthy Korean Male Volunteers. Clinical Therapeutics. 33(6). 728–737. 13 indexed citations

Lim, Kyoung Soo, In‐Jin Jang, Bo‐Hyung Kim, et al.. (2010). Changes in the QTc interval after administration of flecainide acetate, with and without coadministered Paroxetine, in Relation to Cytochrome P450 2D6 Genotype: Data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects. Clinical Therapeutics. 32(4). 659–666. 20 indexed citations

Kim, Bo‐Hyung, Jung‐Ryul Kim, Min‐Gul Kim, et al.. (2010). Pharmacodynamic (Hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: Two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies. Clinical Therapeutics. 32(1). 193–205. 16 indexed citations

Kim, Bo‐Hyung, Kwang‐Hee Shin, Jae Woo Kim, et al.. (2009). Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: A single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers. Clinical Therapeutics. 31(11). 2755–2764. 11 indexed citations

Kim, Tae‐Eun, Bo‐Hyung Kim, Kyoung Soo Lim, et al.. (2009). Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunction. British Journal of Clinical Pharmacology. 68(1). 43–46. 13 indexed citations

Kim, Tae‐Eun, Bo‐Hyung Kim, Jae Woo Kim, et al.. (2009). Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/Ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: An open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers. Clinical Therapeutics. 31(10). 2249–2257. 4 indexed citations

10.

Lim, Kyoung Soo, Joo‐Youn Cho, Bo‐Hyung Kim, et al.. (2009). Pharmacokinetics and pharmacodynamics of LC15‐0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers. British Journal of Clinical Pharmacology. 68(6). 883–890. 35 indexed citations

11.

Kim, Bo‐Hyung, Hyeong‐Seok Lim, Jae‐Yong Chung, et al.. (2008). Safety, tolerability and pharmacokinetics of udenafil, a novel PDE‐5 inhibitor, in healthy young Korean subjects. British Journal of Clinical Pharmacology. 65(6). 848–854. 58 indexed citations

12.

Lim, Kyoung Soo, Jung‐Ryul Kim, Yun‐Jung Choi, et al.. (2008). Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: A dose—block-randomized, double-blind, placebo-controlled, ascending single-dose, phase I study. Clinical Therapeutics. 30(10). 1817–1830. 39 indexed citations

13.

Kim, Jung‐Ryul, Joo‐Youn Cho, Do‐Hyung Kang, et al.. (2008). Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients. British Journal of Clinical Pharmacology. 66(6). 802–810. 45 indexed citations

14.

Choi, Ji‐Yeob, Eunil Lee, Dong‐Young Noh, et al.. (2006). Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer. Breast Cancer Research and Treatment. 100(2). 213–218. 31 indexed citations

15.

Lim, Hyeong‐Seok, Joo‐Youn Cho, Dal‐Seok Oh, et al.. (2006). Angiotensin II type 1 receptor 1166A/C polymorphism in association with blood pressure response to exogenous angiotensin II. European Journal of Clinical Pharmacology. 63(1). 17–26. 11 indexed citations

16.

Yu, Kyung‐Sang, Kyun‐Seop Bae, Ji‐Hong Shon, et al.. (2003). Pharmacokinetic and Pharmacodynamic Evaluation of a Novel Proton Pump Inhibitor, YH1885, in Healthy Volunteers. The Journal of Clinical Pharmacology. 44(1). 73–82. 60 indexed citations

17.

Cho, Joo‐Youn, Kyung‐Sang Yu, In‐Jin Jang, et al.. (2002). Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19. British Journal of Clinical Pharmacology. 53(4). 393–397. 38 indexed citations

18.

Jang, In‐Jin, Kyung‐Sang Yu, Ji‐Hong Shon, et al.. (2000). Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Potassium Channel Opener, SKP‐450, in Healthy Volunteers. The Journal of Clinical Pharmacology. 40(7). 752–761. 4 indexed citations

19.

Shin, Sang‐Goo, et al.. (1988). Diet-Induced Changes in Trough Theophylline Concentrations in an Elderly Asthmatic Patient. CHEST Journal. 93(5). 1113–1114. 1 indexed citations

20.

Shin, Sang‐Goo, et al.. (1988). Theophylline pharmacokinetics in normal elderly subjects. Clinical Pharmacology & Therapeutics. 44(5). 522–530. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact